Maxim Gorbachev
Directeur/Membre du Conseil chez binx health, inc.
Profil
Maxim Gorbachev is currently the Director at binx health, inc.
and the Managing Partner at RMI Partners OOO.
He previously worked as a Director at Celtaxsys, Inc. from 2015 to 2018, and as an Associate Director-Business Planning at Sukhoi Civil Aircraft JSC in 2012.
He also served as an Independent Director at Neothetics, Inc. and as the Director-Finance & Administration at UCB Pharma LLC in 2009 to 2012.
Additionally, he was an Independent Class I Director at Mist Holdings, Inc. from 2013 to 2017 and a Manager-Investment at Sminex LLC.
Mr. Gorbachev holds a graduate degree from Moscow State University Lomonosov, an MBA from Vlerick Leuven Gent Management School, and another graduate degree from Financial University.
Postes actifs de Maxim Gorbachev
| Sociétés | Poste | Début |
|---|---|---|
binx health, inc.
 binx health, inc. Information Technology ServicesTechnology Services Binx Health, Inc. develops and provides in vitro point-of-care (POC) testing on diseases such as sexually transmitted infections, neonatal sepsis and hospital acquired infections. Its technology products include in diagnostic and immunoassay platform, rapid POC, and nucleic acid detection technology. The company was founded by John Clarkson in 2005 and is headquartered in Trowbridge, the United Kingdom. | Directeur/Membre du Conseil | - |
RMI Partners OOO
 RMI Partners OOO Investment ManagersFinance RusnanoMedInvest (RMI) is a subsidiary of RUSNANO, a 100 percent Russian state-owned company whose mission is to develop the Russian nanotechnology industry through co investment in nanotechnology projects with substantial economic potential or social benefit. RMI was founded in 2012 headquartered in Russian. The firm to realize advanced projects in medicine and pharmaceuticals involving the transfer of intellectual property rights and modern pharmaceutical production technology to Russia. | Corporate Officer/Principal | - |
Anciens postes connus de Maxim Gorbachev
| Sociétés | Poste | Fin |
|---|---|---|
Celtaxsys, Inc.
 Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Directeur/Membre du Conseil | 01/12/2018 |
| MIRAMAR LABS INC | Directeur/Membre du Conseil | 25/07/2017 |
Sukhoi Civil Aircraft JSC
 Sukhoi Civil Aircraft JSC Aerospace & DefenseElectronic Technology Sukhoi Civil Aircraft JSC engages in the development and manufacturing of aircraft. Its activities include design and manufacturing of new models of civil aircraft, as well as certification, general project management, sales and after sales support. The company was founded on May 25, 2000 and is headquartered in Moscow, Russia. | Corporate Officer/Principal | 01/03/2013 |
| UCB Pharma LLC | Directeur Financier/CFO | 01/02/2012 |
| Sminex LLC | Directeur en chef des Investissements | - |
Formation de Maxim Gorbachev
| Moscow State University Lomonosov | Graduate Degree |
| Vlerick Leuven Gent Management School | Masters Business Admin |
| Financial University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Miramar Technologies, Inc
 Miramar Technologies, Inc Medical SpecialtiesHealth Technology Miramar Technologies, Inc. develops and provides medical devices for dermatologic medical conditions. It specializes in microwave energy positioned to be adopted for dermatologic conditions. The company was founded by Henry A. Plain Jr., Mark E. Deem and Steven Kim in 2006 and is headquartered in Half Moon Bay, CA. | Health Technology |
| UCB Pharma LLC | |
Neothetics, Inc.
 Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | Health Technology |
Sukhoi Civil Aircraft JSC
Sukhoi Civil Aircraft JSC Aerospace & DefenseElectronic Technology Sukhoi Civil Aircraft JSC engages in the development and manufacturing of aircraft. Its activities include design and manufacturing of new models of civil aircraft, as well as certification, general project management, sales and after sales support. The company was founded on May 25, 2000 and is headquartered in Moscow, Russia. | Electronic Technology |
binx health, inc.
binx health, inc. Information Technology ServicesTechnology Services Binx Health, Inc. develops and provides in vitro point-of-care (POC) testing on diseases such as sexually transmitted infections, neonatal sepsis and hospital acquired infections. Its technology products include in diagnostic and immunoassay platform, rapid POC, and nucleic acid detection technology. The company was founded by John Clarkson in 2005 and is headquartered in Trowbridge, the United Kingdom. | Technology Services |
RMI Partners OOO
RMI Partners OOO Investment ManagersFinance RusnanoMedInvest (RMI) is a subsidiary of RUSNANO, a 100 percent Russian state-owned company whose mission is to develop the Russian nanotechnology industry through co investment in nanotechnology projects with substantial economic potential or social benefit. RMI was founded in 2012 headquartered in Russian. The firm to realize advanced projects in medicine and pharmaceuticals involving the transfer of intellectual property rights and modern pharmaceutical production technology to Russia. | Finance |
Celtaxsys, Inc.
Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Health Technology |
Mist Holdings, Inc.
 Mist Holdings, Inc. Medical SpecialtiesHealth Technology Mist Holdings, Inc. engages in the business of developing and providing medical devices for dermatologic medical treatments. The firm also offers systems, treatments, and practice development programs. The company was founded by Mark E. Deem and Steven W. Kim in 2006 and is headquartered in Santa Clara, CA. | Health Technology |
| Sminex LLC |
